Description
Structure & Identity
The GLOW blend combines three structurally distinct peptides in one vial, each studied through its own mechanism. BPC-157 is a 15-amino-acid synthetic peptide sequence, most often discussed in angiogenesis and nitric-oxide-pathway research. TB-500 is the full-length, 43-residue acetylated form of thymosin beta-4. GHK-Cu is a copper-bound tripeptide (glycyl-histidyl-lysine complexed with copper(II)) studied for its redox chemistry as a copper carrier. Grouping them lets researchers work across three distinct signaling angles, angiogenic, cytoskeletal, and redox, in one preparation. The three are mixed, not chemically joined, so each keeps its own structure.
Research Background
The blend covers tissue-signaling and copper-peptide research threads.
- BPC-157 signaling. Studied for angiogenesis and nitric-oxide-pathway signaling [PMID: 30915550].
- TB-500 actin biology. An actin-sequestering, actin-regulating peptide [PMID: 16099219].
- GHK-Cu oxidative stress. Studied for redox activity in oxidative-stress assays [PMID: 22666519].
- GHK-Cu gene-expression study. Extracellular-matrix-related gene-expression readouts in a rodent model [PMID: 25731775].
- Connective-tissue thread. GHK-Cu’s copper-carrier chemistry connects the blend to redox and metal-biology research.
These are research contexts, not approved uses, and the blend is intended for laboratory study.
Specifications
| Attribute | Value |
| Product type | Blend (one vial) |
| Component 1 | BPC-157, 10 mg (CAS 137525-51-0, MW 1419.5 Da) |
| Component 2 | TB-500 (full-length thymosin beta-4), 10 mg (CAS 77591-33-4, MW 4963.55 Da) |
| Component 3 | GHK-Cu (copper tripeptide), 50 mg (CAS 89030-95-5, MW ~404 Da) |
| Purity | ≥99% by reverse-phase HPLC (each) |
| Identity | Confirmed by ESI mass spectrometry |
| Physical form | Lyophilized powder |
| Storage | -20°C, protected from light |
| Solubility | Soluble in water/DMSO for assay preparation |
| Classification | Research use only |
Storage & Handling
Keep the sealed vial frozen at -20°C and shielded from light until use. After preparation for your assay, store each solution at 2-8°C and use in your study within about two weeks. Warm the vial to room temperature before opening, and avoid repeated freeze-thaw cycles. GHK-Cu dissolves to a blue-tinged solution, which is normal for the copper complex.
Quality Assurance
All three peptides are produced under research-grade manufacturing controls and verified by an independent lab before release. Purity is measured by reverse-phase HPLC and identity by mass spectrometry, with testing carried out by third-party laboratories, including Janoshik Analytical and domestic US labs. The vial ships with a batch-specific certificate of analysis covering all three components.
Frequently Asked Questions
What is in the GLOW blend?
Three peptides pre-combined in one vial: TB-500 10 mg, BPC-157 10 mg, and GHK-Cu 50 mg. It is studied across tissue-signaling and connective-tissue research and supplied for research use only.
How is the GLOW Kit different from the GLOW blend?
The blend has the three peptides pre-combined in one vial; the kit supplies them as three separate vials. Choose the blend for a single pre-combined vial, the kit for handling each peptide separately.
Is TB-500 in this blend the “Ac-SDKP” fragment?
No. TB-500 here is full-length thymosin beta-4 (43 amino acids). Ac-SDKP is a different peptide entirely and is not what TB-500 refers to.
Why is GHK-Cu’s solution blue?
The blue tint comes from the copper(II) ion carried by the GHK tripeptide, which is normal for a genuine GHK-Cu preparation.
Does the blend come with a COA?
Yes. One batch-specific certificate of analysis covers all three peptides in the vial.
Is the GLOW blend FDA approved?
No. None of the components is FDA approved. The blend is a research-use-only preparation, not for human or veterinary use.
How should the blend be stored?
Keep the powder frozen at -20°C and protected from light until use. As with all lyophilized peptides, preparation should follow your lab’s own protocols.
How are the peptides verified?
Each is tested to ≥99% purity by reverse-phase HPLC with mass-spec identity confirmation by an independent lab.
Further reading
- GHK-Cu, BPC-157 and TB-500 blend: composition, ratio and COA guide
- Peptide blends vs single vials: which format to order
